Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Dysfunction in the Transition from NASH to HCC
Mélissa Leveille, Jennifer L. Estall
Metabolites (2019) Vol. 9, Iss. 10, pp. 233-233
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
Biomolecules (2022) Vol. 12, Iss. 6, pp. 824-824
Open Access | Times Cited: 241
Oxidative Stress in Liver Pathophysiology and Disease
Abdolamir Allameh, Reyhaneh Niayesh‐Mehr, Azadeh Aliarab, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1653-1653
Open Access | Times Cited: 126
Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress
Alimire Abulikemu, Xinying Zhao, Hailin Xu, et al.
Redox Biology (2022) Vol. 59, pp. 102569-102569
Open Access | Times Cited: 71
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2844-2844
Open Access | Times Cited: 46
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Hyun-Mi Kim, Da Som Lee, Tae Hyeon An, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4495-4495
Open Access | Times Cited: 99
Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress
Sabira Mohammed, Evan H. Nicklas, Nidheesh Thadathil, et al.
Free Radical Biology and Medicine (2021) Vol. 164, pp. 315-328
Open Access | Times Cited: 91
Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease
Pankaj Prasun, Ilona Ginevic, Kimihiko Oishi
Translational Gastroenterology and Hepatology (2020) Vol. 6, pp. 4-4
Open Access | Times Cited: 76
Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD
Ruth C. R. Meex, Ellen E. Blaak
Molecular Nutrition & Food Research (2020) Vol. 65, Iss. 1
Open Access | Times Cited: 75
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
Aigli‐Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, et al.
Current Obesity Reports (2022) Vol. 11, Iss. 3, pp. 126-143
Open Access | Times Cited: 52
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan
Comprehensive physiology (2022), pp. 3167-3192
Open Access | Times Cited: 44
Role of lncRNAs in hepatocellular carcinoma
Smriti Verma, Bidya Dhar Sahu, Madhav Nilakanth Mugale
Life Sciences (2023) Vol. 325, pp. 121751-121751
Closed Access | Times Cited: 22
Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe
Xiaofei Fan, Lin Lin, Binxin Cui, et al.
Pharmacological Research (2020) Vol. 159, pp. 104945-104945
Closed Access | Times Cited: 64
The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond
Hung‐Yu Lin, Ya‐Ling Yang, Pei‐Wen Wang, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 1041-1041
Open Access | Times Cited: 63
Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
Sandra Torres, Paula Segalés, Carmen García‐Ruiz, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1475-1475
Open Access | Times Cited: 34
Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease
Jun‐Hyuk Lee, Hye Sun Lee, Sang Bong Ahn, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 10, pp. 5252-5260
Closed Access | Times Cited: 39
Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics
Rocı́o I.R. Macı́as, María J. Monte, María A. Serrano, et al.
Aging (2021) Vol. 13, Iss. 19, pp. 23416-23434
Open Access | Times Cited: 33
Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 11, pp. 159209-159209
Closed Access | Times Cited: 22
Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
Madan Kumar Arumugam, Thiyagarajan Gopal, Rakhee Rathnam Kalari Kandy, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1311-1311
Open Access | Times Cited: 14
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
Vittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2521-2521
Open Access | Times Cited: 13
Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study
Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 9, pp. 1529-1536
Closed Access | Times Cited: 4
Natural compounds proposed for the management of non-alcoholic fatty liver disease
Théodora Merenda, Florian Juszczak, Elisabeth Ferier, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review
Bo Hu, Jianzhen Lin, Xiaobo Yang, et al.
Cell Proliferation (2020) Vol. 53, Iss. 4
Open Access | Times Cited: 34
Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
Jimin Kim, Seul Ki Lee, Seon-Yeong Jeong, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 27
Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis
Eman Ahmed, Marwa O. El-Derany, Ali Mostafa Anwar, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 210-210
Open Access | Times Cited: 20
The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
Camelia Munteanu, Betty Schwartz
Antioxidants (2023) Vol. 12, Iss. 4, pp. 903-903
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top